We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
DASA seeks innovations to enhance operational advantage through improved self suffiency and energy innovation
British AI company Wayve announces $1.05 billion investment to develop the next generation of AI-powered self-driving vehicles
The recipients of this year's King's Awards for Enterprise announced
Winners of DWP’s Disability Confident Awards crowned in night of disability employment celebration.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How we are going to deliver our mission to grow the UK economy by providing an IP system that encourages investment in creativity and innovation.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Find out about the long-term effects some people can have after having COVID-19.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
Legal standards for labelling and composition of food products such as bottled water, milk and meat.
Using an ecological momentary assessment to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information to support your recovery after COVID-19.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
The Fund aims to create the opportunity to build strong partnerships between UK and Turkish scientists, researchers and institutions.
Advice for medical professionals to follow when assessing drivers with drug or alcohol misuse or dependence.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.